Similar Papers

Paper Title
Journal
Date
Author
A phase I clinical trial of stereotactic body radiotherapy with atezolizumab and bevacizumab in advanced hepatocellular carcinoma.
Timothy J Brown ... Andy J Minn
Journal of Clinical Oncology | VOL. 41
Timothy J Brown, et. al.Timothy J Brown ... Andy J Minn
01 Feb 2023
Systemic cytotoxic and biologic therapies for colorectal cancer liver metastases: expert consensus statement
Bryan M Clary ... Robert D.W Marsh
HPB | VOL. 15
Bryan M Clary, et. al.Bryan M Clary ... Robert D.W Marsh
01 Feb 2013
Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?
Ivan V Litvinov ... John T Isaacs
The Journal of Clinical Endocrinology & Metabolism | VOL. 88
Ivan V Litvinov, et. al.Ivan V Litvinov ... John T Isaacs
01 Jul 2003
Systemic therapy with calcitonin has positive clinical effects on systemic sclerosis in patients with cutaneous manifestations.
Laura Streiff ... Ugur Uslu
European journal of dermatology : EJD | VOL. 28
Laura Streiff, et. al.Laura Streiff ... Ugur Uslu
01 May 2018
View more papers

More From: JCO oncology practice

Paper Title
Journal
Date
Author
Real-World Evidence of Combination Therapy Use in Metastatic Hormone-Sensitive Prostate Cancer in the United States From 2017 to 2023.
Amit D Raval ... Daniel J George
JCO oncology practice | VOL. -
Amit D Raval, et. al.Amit D Raval ... Daniel J George
07 Feb 2025
Financial Distress Screening and Navigation in Pediatric Oncology Within the National Cancer Institute Community Oncology Research Program.
Joanna M Robles ... Melissa P Beauchemin
JCO oncology practice | VOL. -
Joanna M Robles, et. al.Joanna M Robles ... Melissa P Beauchemin
06 Feb 2025
Continued Promise and Possibility of Prospective Payment System Exemption: An Investment in the Future of Cancer Care Innovation.
Sean M Mcbride ... Craig A Bunnell
JCO oncology practice | VOL. -
Sean M Mcbride, et. al.Sean M Mcbride ... Craig A Bunnell
05 Feb 2025
Rethinking the Chosen Eleven
Chirag Shah
JCO Oncology Practice | VOL. -
Chirag ShahChirag Shah
05 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.